Lactato De Ringer Fresenius (Potassium Chloride, Sodium Chloride, Calcium Chloride Dihydrate, Sodium Lactate (As 50% Solution))

The solution provides sodium, potassium, calcium, and lactate ions directly into the bloodstream. Sodium and chloride expand extracellular fluid volume, while potassium and calcium replenish essential electrolytes. Lactate is metabolized by the liver into bicarbonate, aiding in the correction of metabolic acidosis and supporting overall acid‑base balance.

The prescribed dose of Lactato De Ringer Fresenius is determined by the treating clinician based on the patient’s fluid status, electrolyte needs, and clinical condition. Dosage is individualized and administered intravenously under medical supervision.

Safety data for Lactato De Ringer Fresenius in pregnancy and lactation are limited. Use should be considered only if the potential benefit justifies any potential risk to the fetus or infant, and it should be administered under the guidance of a qualified healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Lactated Ringer's solution differs from normal saline by containing potassium, calcium, and lactate, which more closely mimic plasma electrolyte composition. This reduces the risk of hyperchloremic acidosis associated with saline and provides metabolic benefits through lactate conversion to bicarbonate, making it preferable for many surgical and trauma patients.

Store the solution at room temperature, protected from light, and keep it in the original sealed container. Do not freeze or shake the bag vigorously. Ensure the product is used before the expiration date and that aseptic techniques are followed during preparation and administration.

Lactato De Ringer Fresenius is administered intravenously, typically via a peripheral or central venous line. The infusion rate is set by the prescribing clinician based on the patient’s hemodynamic status, target fluid volume, and electrolyte goals, and it is monitored continuously during administration.

Serious risks include severe hyperkalemia, fluid overload leading to pulmonary edema, anaphylactic reactions, and significant electrolyte disturbances such as hypernatremia or hypercalcemia. Prompt monitoring of cardiac rhythm, fluid balance, and electrolyte levels is essential to detect and manage these complications early.

Patients with known severe hyperkalemia, uncontrolled fluid overload, severe liver disease impairing lactate metabolism, or documented hypersensitivity to any component of the solution should not receive Lactato De Ringer Fresenius. Clinicians should evaluate individual risk factors before prescribing.